Aamir Jamal is a Nephrology physician. OpenAlex indexes 6 publications with 440 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1335 Cypress Street,
Suite 205
San Dimas, CA 917733538
Telephone
909-542-2777Provider last certified this registry record 28 Aug 2020.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20256 payments
- AKEBIA THERAPEUTICS INCProgram year20259 payments
- Amgen Inc.Program year202515 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
46.6%Calcium channel blocker9%Amlodipine Besylate63%Nifedipine Er31%Amlodipine-Valsartan6%Part D<11 patientsBeta blocker8.4%Metoprolol Succinate39%Metoprolol Tartrate39%Carvedilol21%Part D≥31 patients+ 11 more classes in this area
Metabolism & gastrointestinal
24.9%Proton pump inhibitor4.9%Pantoprazole Sodium83%Omeprazole17%Part D<11 patientsSGLT2 inhibitor3.8%Farxiga100%Part D≥28 patients+ 11 more classes in this area
Other
7.1%Drugs for treatment of hyperkalemia and hyperphosphatemia4.5%Lokelma50%Velphoro29%Auryxia22%Part D<11 patientsPhosphate Binder2.6%Sevelamer Hcl62%Sevelamer Carbonate38%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Real-World Urea Clearance and Adequacy with the Moda-flx Hemodialysis System
Journal of the American Society of Nephrology
2025 - Hemodialysis Access Surveillance Evaluation (HASE) Study
Journal of the American Society of Nephrology
2020 - A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
New England Journal of Medicine
2019 - Lower-extremity saphenous vein transposition arteriovenous fistula: an alternative for hemodialysis access in AIDS patients.
PubMed
1998
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”